Rushmore Compounding Pharmacy (CSRX Inc.), Rapid City, SD
Is Rushmore Compounding Pharmacy (CSRX Inc.) registered with the FDA as a 503B outsourcing facility?
No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.
Does Rushmore Compounding Pharmacy (CSRX Inc.) hold a South Dakota pharmacy license?
State board of pharmacy records for South Dakota are not checked: this index has not yet added that board’s records.
Has Rushmore Compounding Pharmacy (CSRX Inc.) had a state board action or FDA letter?
FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 FMD-145 letter (Feb 19, 2019) for Rushmore Compounding Pharmacy (CSRX Inc.). State board of pharmacy records for South Dakota are not checked: this index has not yet added that board’s records.
FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.
- Names in FDA records
- CSRX Inc.; Rushmore Compounding Pharmacy
- Location
- Rapid City, SD
- Type as FDA labels it
- 503A
- FDA 503B list
- No matching record found
- Form 483s on FDA’s actions page
- 0
- Warning letters on FDA’s actions page
- 0
- Latest action on that page
- Feb 19, 2019
- FDA Data Dashboard inspections
- 1 inspection: 1 VAI; 0 published Form 483s
- State board records
- Not checked
FDA inspections and letters
FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as CSRX Inc., (dba Rushmore Compounding Pharmacy), a 503A facility, with 1 dated action.
| Document | |||
|---|---|---|---|
| Feb 19, 2019 | FMD-145 letter | FMD-145 Letter Issued 02/19/2019 | FDA copy (archived) |
An untitled or FMD-145 letter states FDA’s view when it was issued.
FDA inspection classifications and published Form 483s
The FDA Data Dashboard, read Nov 15, 2026, lists CSRX Inc., Rapid City, SD (FEI number 3012088586), matched to this page by exact name, city and state. It lists 1 inspection: 1 VAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.
| Inspection ended | Classification | Project area and product type | FEI | Inspection ID |
|---|---|---|---|---|
| Jul 15, 2016 | Voluntary Action Indicated (VAI) | Drug Quality Assurance (Drugs) | 3012088586 | 979046 |
Form 483s FDA has published for this site
No published Form 483 for FEI 3012088586 was found in the dashboard’s list of published 483s on Nov 15, 2026. FDA publishes only some 483s, so this does not mean none was issued.
FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.
State board of pharmacy records
State board of pharmacy records for South Dakota are not checked: this index has not yet added that board’s records.
This page restates FDA’s lists. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.
Sources
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA Registered Outsourcing Facilities (503B)
- FDA Data Dashboard: inspection classifications and published Form 483s
Records last pulled Nov 15, 2026. Every entry links to the original public record.